Blood marker study in teens with juvenile arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at blood (and related) markers that may reflect inflammation in people with juvenile idiopathic arthritis. It may help doctors better understand disease activity and guide future care for patients who are able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 16 or older
- You have been diagnosed with juvenile idiopathic arthritis and receive rheumatology follow-up at Cochin Hospital
- You agree to take part in the research (no refusal/objection)
- You have health insurance
- You can understand and speak French well enough to participate
- You are not under guardianship or legal supervision
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a simple daily activities test works well for children and teens with juvenile idiopathic arthritis. It may help doctors better understand how the condition affects everyday tasks.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study collects fluid from your joints (synovial fluid) or tissue from joint replacement surgery to look for biomarkers (biological clues) that could help doctors better diagnose bone and joint diseases.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
This study looks at certain blood tests in children with juvenile idiopathic arthritis (JIA) to see if they can help measure how active the disease is. The goal is to find simpler ways to track arthritis activity and guide treatment.
This study looks at two substances in the blood (IL-18 and IL-18BP) to see if they can help doctors tell apart different causes of fever and inflammation in children. It might help find better ways to diagnose conditions like juvenile idiopathic arthritis and autoinflammatory diseases.
Hear when a new Juvenile Idiopathic Arthritis (JIA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.